Overview of our service
BioReperia has developed a unique zebrafish technology platform for evaluating efficacy and toxicity for your substances. Our models enable you to select the leads that have highest potential to success as drug candidates.
Reach your goals faster
By using zebrafish as models within toxicology and drug-discovery in oncology we allow identification of drug actions and toxicity under conditions very similar to that in patients, in a matter of days. This makes our methods cheaper and faster than other in vivo studies, but more precise than ordinary in vitro experiments. By combining a wide range of complementary analyses, market-leading statistical power and customized analysis-packages we ensure the highest precision and most reliable results possible to perfectly fit our customer’s needs.